Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  563,557 results for ""Drug Interactions""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Drug Interactions.

  • Authors : Janković SM; Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića Street, 69, 34000, Kragujevac, Serbia. .; Janković SV

Subjects: Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/drug therapy ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/pharmacokinetics

  • Source: European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2024 May; Vol. 49 (3), pp. 263-275.Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Statin Drug-Drug Interactions: Pharmacokinetic Basis of FDA Labeling Recommendations and Comparison Across Common Tertiary Clinical Resources.

  • Authors : Mease J; Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, MD, USA.; Ramamoorthy A

Subjects: Drug Interactions* ; United States Food and Drug Administration* ; Drug Labeling*/Drug Labeling*/Drug Labeling*/standards

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2024 Jun; Vol. 64 (6), pp. 704-712. Date of Electronic Publication: 2024 Feb 01.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604

Record details

Read More Add to Saved list
×
Academic Journal

Drug-Drug Interactions and Their Association with Adverse Health Outcomes in the Older Community-Dwelling Population: A Prospective Cohort Study.

  • Authors : Hughes JE; School of Population Health, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland. .; Bennett KE

Subjects: Drug Interactions* ; Quality of Life* ; Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/epidemiology

  • Source: Clinical drug investigation [Clin Drug Investig] 2024 Jun; Vol. 44 (6), pp. 439-453. Date of Electronic Publication: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Mechanistic Determinants of Daprodustat Drug-Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B-CYP2C8 Interplay.

  • Authors : Bi YA; Pharmacokinetics, Dynamics, and Metabolism, Pfizer R&D, Pfizer Inc., Groton, Connecticut, USA.; Jordan S

Subjects: Cytochrome P-450 CYP2C8*/Cytochrome P-450 CYP2C8*/Cytochrome P-450 CYP2C8*/metabolism ; Drug Interactions* ; Hepatocytes*/Hepatocytes*/Hepatocytes*/metabolism

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1336-1345. Date of Electronic Publication: 2024 Feb 26.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Read More Add to Saved list
×
Academic Journal

PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug-drug interactions with clarithromycin and paroxetine.

  • Authors : Cho CK; School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.; Kang P

Subjects: Venlafaxine Hydrochloride*/Venlafaxine Hydrochloride*/Venlafaxine Hydrochloride*/pharmacokinetics ; Venlafaxine Hydrochloride*/Venlafaxine Hydrochloride*/Venlafaxine Hydrochloride*/administration & dosage ; Clarithromycin*/Clarithromycin*/Clarithromycin*/pharmacokinetics

  • Source: Archives of pharmacal research [Arch Pharm Res] 2024 May; Vol. 47 (5), pp. 481-504. Date of Electronic Publication: 2024 Apr 25.Publisher: Pharmaceutical Society of Korea Country of Publication: Korea (South) NLM ID: 8000036 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×

Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review.

  • Authors : Calvarysky B; Pharmacy, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Subjects: Drug Interactions* ; Glucagon-Like Peptide 1*; Humans

  • Source: Drug safety [Drug Saf] 2024 May; Vol. 47 (5), pp. 439-451. Date of Electronic Publication: 2024 Jan 25.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants: an intervention study in community pharmacies.

  • Authors : Capiau A; Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium. Electronic address: .; Mehuys E

Subjects: Drug Interactions* ; Anticoagulants*/Anticoagulants*/Anticoagulants*/therapeutic use; Humans

  • Source: Thrombosis research [Thromb Res] 2024 Jun; Vol. 238, pp. 223-231. Date of Electronic Publication: 2024 May 07.Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Inhibition of human UDP-glucuronosyltransferase enzyme by entrectinib: Implications for drug-drug interactions.

  • Authors : Yin H; School of Chemical Engineering, Ocean and Life Sciences, Dalian University of Technology, Panjin, 124221, China.; Wang Z

Subjects: Glucuronosyltransferase*/Glucuronosyltransferase*/Glucuronosyltransferase*/metabolism ; Glucuronosyltransferase*/Glucuronosyltransferase*/Glucuronosyltransferase*/antagonists & inhibitors ; Drug Interactions*

  • Source: Chemico-biological interactions [Chem Biol Interact] 2024 May 25; Vol. 395, pp. 111023. Date of Electronic Publication: 2024 Apr 25.Publisher: Elsevier Country of Publication: Ireland NLM ID: 0227276 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7786

Record details

Read More Add to Saved list
×
Academic Journal

In Vitro Investigations into the Potential Drug Interactions of Pseudoginsenoside DQ Mediated by Cytochrome P450 and Human Drug Transporters.

  • Authors : Li Z; School of Pharmaceutical Sciences, Jilin University, 126 Xinmin Street, Changchun 130021, China.; Wang C

Subjects: Ginsenosides*/Ginsenosides*/Ginsenosides*/pharmacology ; Ginsenosides*/Ginsenosides*/Ginsenosides*/chemistry ; Drug Interactions*

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 May 24; Vol. 29 (11). Date of Electronic Publication: 2024 May 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

Read More Add to Saved list
×
Academic Journal

A genetic algorithm-based approach for the prediction of metabolic drug-drug interactions involving CYP2C8 or CYP2B6.

  • Authors : Di Paolo V; Laboratory of Drug Metabolism, Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy. Electronic address: .; Ferrari FM

Subjects: Drug Interactions*/Drug Interactions*/Drug Interactions*/physiology ; Cytochrome P-450 CYP2B6*/Cytochrome P-450 CYP2B6*/Cytochrome P-450 CYP2B6*/metabolism ; Cytochrome P-450 CYP2B6*/Cytochrome P-450 CYP2B6*/Cytochrome P-450 CYP2B6*/genetics

  • Source: Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2024 May-Jun; Vol. 127, pp. 107516. Date of Electronic Publication: 2024 May 20.Publisher: Elsevier Country of Publication: United States NLM ID: 9206091 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  563,557 results for ""Drug Interactions""